No Data
Jiangxi Rimag's Profit Plunges 91% in H1
The first interim performance report of Yimaiyangguang after listing. The revenue of Yimaiyun increased by 123.3% year-on-year.
On August 27, Yimai Sunshine, the first medical imaging service listed on the Hong Kong stock market, released its first interim performance report. The data shows that for the six months ending June 30, 2024, Yimai Sunshine's revenue was approximately 0.414 billion yuan, a year-on-year decrease of 21.9%; gross profit was approximately 0.16 billion yuan, a slight decrease of 15.4% compared to the same period last year. Yimai Sunshine's interim performance maintains stable growth compared to the second half of 2023. The main revenue increased by 3.7% compared to the previous period, and the gross profit increased by 15.7 million yuan, a year-on-year increase of 109% in net income. Adjusted net income and adjusted
Performance: OneSun (02522.HK) net profit for the first half of the year was CNY 3.84 million, a decrease of 91.1% and no dividend.
Yimaiyangguang (02522.HK) announced its interim performance for the six months ending in June, with revenue of 0.414 billion RMB, a year-on-year decrease of 21.9%. It recorded a net profit of 3.84 million yuan, a decline of 91.1%, with earnings per share of 1.1 cents. No interim dividend will be distributed.
Yanqiu Sun (02522) announced its interim results, with the company's attributable profit declining by 91.1% to 3.836 million yuan year-on-year.
Evergrande Sunshine (02522) announced its mid-term performance in 2024, with revenue of approximately 0.414 billion yuan, a year-on-year decrease of 21.9...
RIMAG GROUP: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHSENDED JUNE 30, 2024
Jiangxi Rimag Group Announces Upcoming Board Meeting
No Data
No Data